retatrutide weight loss clinical data just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a phase 2 study: • Up to 24.2% mean at 48 weeks Retatrutide hits 28% weight loss

The data work was led by medical doctor and PhD student Mads Brner together with PhD student Amalie Broks

Nat Med 23:859868

In concert with IFN-, mainly released by T cells, IFN- also increases HLA-I expression directly on infected cells 2 , thus augmenting their antigenic visibility, and enhances the cytolytic activity and survival of natural killer (NK) and CD8 + T cells 3

Reconstitution Steps Before starting, allow the vial to sit at room temperature for 1520 minutes to prevent condensation

Some individuals may experience mild reactions at injection sites or shifts in appetite due to hormonal changes promoted by the treatment

It is important to clarify that while weight loss is a common and beneficial side effect of Ozempic, it is not FDA-approved specifically for weight loss